2. Athersys (ATHX) is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. The company's product development portfolio includes MultiStem, a stem cell product under development for treating multiple diseases. MultiStem is being evaluated in two ongoing clinical trials and has been authorized for use in a third clinical trial.
9 Health Care Stocks With 100% Buy Ratings
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.